Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Clin Cancer Res. 2017 Aug 23;24(4):730–736. doi: 10.1158/1078-0432.CCR-17-1355

Figure 1.

Figure 1

A generic two-stage sequential multiple assignment randomized trial (SMART) design where participants are randomized between any number of treatments A1 to AJ. Response is measured at some intermediate time point or over time such that responders are re-randomized in the second stage between any number of treatments B1 to BK and non-responders are re-randomized between any number of treatments C1 to CL. The same participants are followed throughout the trial.